Literature DB >> 9210987

Use of a modified version of the Overt Aggression Scale in the measurement and assessment of aggressive behaviours following brain injury.

N Alderman1, C Knight, C Morgan.   

Abstract

Aggressive behaviour creates a significant challenge in neurorehabilitation. Despite the success in using behaviour modification principles in the treatment of post-acute behavioural problems, psychopharmacological approaches to the management of aggression are more frequently reported. However, inconsistencies apparent in the literature hinder inter-study comparisons of treatment methods. These include severity of brain injury, neuropsychological status and rigour of experimental methodology used. Data about aggression is also inconsistently reported, especially with regard to classification and severity. Descriptions of how aggressive behaviour responded to pre-treatment is also generally absent. In this paper an observational rating scale is described in an attempt to address these inconsistencies. The Overt Aggression Scale has been modified by increasing the range of interventions to reflect current practice in neurorehabilitation, and by changing the language to make it suitable for UK users. A range of antecedents has also been added to make the scale useful in behavioural analysis. Preliminary results indicate inter-rater reliability is good, and it is a valid indicator of type and severity of aggression. Antecedents and interventions used in the management of aggressive behaviours in neurorehabilitation are also illustrated. Clinical use of the scale is also discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9210987

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  10 in total

1.  The relational neurobehavioral approach: can a non-aversive program manage adults with brain injury-related aggression without seclusion/restraint?

Authors:  Raj K Kalapatapu; Gordon M Giles
Journal:  Disabil Rehabil       Date:  2016-09-16       Impact factor: 3.033

2.  The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes.

Authors:  Beatrice A Golomb; Michael H Criqui; Halbert L White; Joel E Dimsdale
Journal:  Control Clin Trials       Date:  2004-04

3.  Prevalence of aggressive behaviour after severe paediatric traumatic brain injury.

Authors:  Wesley R Cole; Joan P Gerring; Robert M Gray; Roma A Vasa; Cynthia F Salorio; Marco Grados; James R Christensen; Beth S Slomine
Journal:  Brain Inj       Date:  2008-11       Impact factor: 2.311

4.  Oral self-injuries: clinical findings in a series of 19 patients.

Authors:  Rosangela Cannavale; Angelo Itro; Giuseppina Campisi; Domenico Compilato; Giuseppe Colella
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-03-01

Review 5.  Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic Review.

Authors:  Xin Yu; Christoph U Correll; Yu-Tao Xiang; Yifeng Xu; Jizhong Huang; Fude Yang; Gang Wang; Tianmei Si; John M Kane; Prakash Masand
Journal:  Shanghai Arch Psychiatry       Date:  2016-10-25

6.  Characterizing the experience of agitation in patients with bipolar disorder and schizophrenia.

Authors:  Jenna Roberts; Alfredo Gracia Canales; Sophee Blanthorn-Hazell; Anca Craciun Boldeanu; Davneet Judge
Journal:  BMC Psychiatry       Date:  2018-04-16       Impact factor: 3.630

7.  The Efficacy and Harms of Pharmacological Interventions for Aggression After Traumatic Brain Injury-Systematic Review.

Authors:  Amelia J Hicks; Fiona J Clay; Malcolm Hopwood; Amelia C James; Mahesh Jayaram; Luke A Perry; Rachel Batty; Jennie L Ponsford
Journal:  Front Neurol       Date:  2019-11-29       Impact factor: 4.003

Review 8.  The Psychosocial Impact of Neurobehavioral Disability.

Authors:  Claire Williams; Rodger Llewellyn Wood; Nick Alderman; Andrew Worthington
Journal:  Front Neurol       Date:  2020-02-20       Impact factor: 4.003

9.  A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).

Authors:  Virginie Moulier; Mohamed Wassim Krir; Marine Dalmont; Olivier Guillin; Maud Rothärmel
Journal:  Trials       Date:  2021-04-15       Impact factor: 2.279

10.  Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial.

Authors:  Shoumitro Deb; Lina Aimola; Verity Leeson; Mayur Bodani; Lucia Li; Tim Weaver; David Sharp; Paul Bassett; Mike Crawford
Journal:  BMJ Open       Date:  2020-09-10       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.